CN113425794A - Plaster for treating hyperosteogeny and preparation method thereof - Google Patents
Plaster for treating hyperosteogeny and preparation method thereof Download PDFInfo
- Publication number
- CN113425794A CN113425794A CN202110911510.4A CN202110911510A CN113425794A CN 113425794 A CN113425794 A CN 113425794A CN 202110911510 A CN202110911510 A CN 202110911510A CN 113425794 A CN113425794 A CN 113425794A
- Authority
- CN
- China
- Prior art keywords
- parts
- root
- plaster
- natural resin
- angelica
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010005963 Bone formation increased Diseases 0.000 title claims abstract description 54
- 239000011505 plaster Substances 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title abstract description 13
- 239000003814 drug Substances 0.000 claims abstract description 78
- 239000000025 natural resin Substances 0.000 claims abstract description 65
- 239000000843 powder Substances 0.000 claims abstract description 61
- 239000000919 ceramic Substances 0.000 claims abstract description 45
- 229940079593 drug Drugs 0.000 claims abstract description 43
- 239000002994 raw material Substances 0.000 claims abstract description 43
- 239000000463 material Substances 0.000 claims abstract description 33
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 30
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 22
- 230000000149 penetrating effect Effects 0.000 claims abstract description 22
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 21
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 21
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 21
- 235000002566 Capsicum Nutrition 0.000 claims abstract description 20
- 241000218158 Clematis Species 0.000 claims abstract description 20
- 241000123589 Dipsacus Species 0.000 claims abstract description 20
- 241000208688 Eucommia Species 0.000 claims abstract description 20
- 241001022083 Flemingia Species 0.000 claims abstract description 20
- 239000004863 Frankincense Substances 0.000 claims abstract description 20
- 239000006002 Pepper Substances 0.000 claims abstract description 20
- 235000016761 Piper aduncum Nutrition 0.000 claims abstract description 20
- 235000017804 Piper guineense Nutrition 0.000 claims abstract description 20
- 235000008184 Piper nigrum Nutrition 0.000 claims abstract description 20
- 241000270708 Testudinidae Species 0.000 claims abstract description 20
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 20
- 235000011477 liquorice Nutrition 0.000 claims abstract description 20
- 241001254604 Angelica pubescens Species 0.000 claims abstract description 19
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 19
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 19
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 19
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 19
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 19
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 19
- 241000569924 Pinanga maculata Species 0.000 claims abstract description 19
- 239000009910 sargent gloryvine Substances 0.000 claims abstract description 19
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 17
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 17
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 17
- 241000405414 Rehmannia Species 0.000 claims abstract description 16
- 229940107666 astragalus root Drugs 0.000 claims abstract description 15
- 244000150195 Cyperus longus Species 0.000 claims abstract description 14
- 241000212322 Levisticum officinale Species 0.000 claims abstract description 13
- 239000001645 levisticum officinale Substances 0.000 claims abstract description 13
- 244000061520 Angelica archangelica Species 0.000 claims abstract description 10
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 10
- 244000075634 Cyperus rotundus Species 0.000 claims abstract description 5
- 235000018109 Cyperus longus Nutrition 0.000 claims abstract 4
- 244000182216 Mimusops elengi Species 0.000 claims abstract 4
- 235000005010 Scirpus paludosus Nutrition 0.000 claims abstract 4
- 241000227129 Aconitum Species 0.000 claims description 20
- 241001506371 Kadsura Species 0.000 claims description 19
- 240000003889 Piper guineense Species 0.000 claims description 19
- 241000488974 Loranthus Species 0.000 claims description 18
- 230000003071 parasitic effect Effects 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 18
- 239000002245 particle Substances 0.000 claims description 11
- 238000010298 pulverizing process Methods 0.000 claims description 9
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical group CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 7
- 241000007126 Codonopsis pilosula Species 0.000 claims description 7
- 241000112528 Ligusticum striatum Species 0.000 claims description 7
- 241001478428 Syngnathus Species 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 6
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 238000007789 sealing Methods 0.000 claims description 6
- 230000007480 spreading Effects 0.000 claims description 6
- 238000003892 spreading Methods 0.000 claims description 6
- 229910001220 stainless steel Inorganic materials 0.000 claims description 6
- 239000010935 stainless steel Substances 0.000 claims description 6
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims description 6
- 229920001800 Shellac Polymers 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 239000004208 shellac Substances 0.000 claims description 4
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 claims description 4
- 229940113147 shellac Drugs 0.000 claims description 4
- 235000013874 shellac Nutrition 0.000 claims description 4
- 235000015468 Lycium chinense Nutrition 0.000 claims description 3
- 244000241872 Lycium chinense Species 0.000 claims description 3
- 208000002193 Pain Diseases 0.000 abstract description 32
- 230000036407 pain Effects 0.000 abstract description 32
- 230000000694 effects Effects 0.000 abstract description 25
- 239000008280 blood Substances 0.000 abstract description 22
- 210000004369 blood Anatomy 0.000 abstract description 22
- 230000001737 promoting effect Effects 0.000 abstract description 20
- 210000002435 tendon Anatomy 0.000 abstract description 20
- 238000005728 strengthening Methods 0.000 abstract description 18
- 210000000988 bone and bone Anatomy 0.000 abstract description 17
- 230000017531 blood circulation Effects 0.000 abstract description 13
- 230000009471 action Effects 0.000 abstract description 6
- 238000007669 thermal treatment Methods 0.000 abstract description 6
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 4
- 208000026935 allergic disease Diseases 0.000 abstract description 4
- 230000007815 allergy Effects 0.000 abstract description 4
- 238000002156 mixing Methods 0.000 abstract description 2
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 241001506304 Kadsura japonica Species 0.000 abstract 1
- 244000203593 Piper nigrum Species 0.000 abstract 1
- 241000316342 Taxillus Species 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 18
- 235000019634 flavors Nutrition 0.000 description 18
- 240000002624 Mespilus germanica Species 0.000 description 13
- 235000009508 confectionery Nutrition 0.000 description 11
- 208000006820 Arthralgia Diseases 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 208000005392 Spasm Diseases 0.000 description 6
- 206010042674 Swelling Diseases 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 230000008736 traumatic injury Effects 0.000 description 6
- 235000006533 astragalus Nutrition 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 210000002683 foot Anatomy 0.000 description 4
- 208000034783 hypoesthesia Diseases 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 241000045403 Astragalus propinquus Species 0.000 description 3
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000002045 lasting effect Effects 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 241000243684 Lumbricus Species 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- 206010065369 Burnout syndrome Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 241001256368 Clematis chinensis Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 235000016854 Cyperus rotundus Nutrition 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000008558 Osteophyte Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000501113 Sargentodoxa cuneata Species 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 240000001638 Scurrula parasitica Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 201000010934 exostosis Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000000199 molecular distillation Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000024121 nodulation Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 235000021259 spicy food Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0625—Warming the body, e.g. hyperthermia treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
Abstract
The invention discloses a plaster for treating hyperosteogeny and a preparation method thereof, wherein the plaster for treating hyperosteogeny is prepared from raw material medicines, natural resin, far infrared ceramic powder and penetrant, wherein the raw material medicines comprise Chinese taxillus twig, kadsura pepper stem, clematis root, earthworm, pubescent angelica root, slenderstyle acanthopanax bark, pilose asiabell root, myrrh, frankincense, tsutsutsugami, tiger palm, sargentgloryvine stem, medlar, angelica, szechuan lovage rhizome, dried rehmannia root, astragalus root, dahurian angelica root, eucommia bark, philippine flemingia root, himalayan teasel root, nutgrass galingale rhizome, tortoise plastron, liquorice, kusnezoff monkshood root and sea dragon. The external plaster is prepared by mixing twenty-six medicinal materials with natural resin, far infrared ceramic powder and a penetrating agent, has the effects of dispelling wind and eliminating dampness, promoting blood circulation to remove blood stasis, dredging collaterals and relieving pain, strengthening tendons and bones and the like, greatly accelerates the treatment effect through the combined action of medical treatment and thermal treatment, and has the characteristics of good curative effect, high cure rate, difficult relapse and the like; in addition, the raw materials of the medicinal materials used in the invention have low price, the preparation method is simple, the viscosity is durable, allergy is avoided, the medicinal materials can be repeatedly torn off and pasted, and the use is convenient.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a plaster for treating hyperosteogeny and a preparation method thereof.
Background
Hyperosteogeny, commonly known as "bony spur", is usually caused in joints with heavy load and more movement, such as neck, waist, thoracic vertebra, knee, finger, heel, etc., and is most common in clinical treatment of cervical vertebra and lumbar vertebra. Once suffering from hyperosteogeny, the hyperosteogeny part of the patients can press nerves, blood vessels or other tissues to cause uncomfortable feelings of pain, numbness and the like of the human body, and serious patients can cause that the life cannot be self-managed and even paralysis.
At present, the existing treatment methods are physical therapy and operation, and have the defects of high cost and high risk, and the existing related medicines only play the roles of relieving pain and diminishing inflammation, so that the aim of healing cannot be achieved. To date, no specific method or drug for treating hyperosteogeny has been found.
Disclosure of Invention
In order to solve the problems in the prior art, the invention provides a plaster for treating hyperosteogeny and a preparation method thereof, wherein the plaster is prepared by mixing twenty-six medicinal materials, is prepared by natural resin, far infrared ceramic powder and a penetrating agent, has the effects of dispelling wind and eliminating dampness, promoting blood circulation to remove blood stasis, dredging collaterals and relieving pain, strengthening tendons and bones and the like, and has the combined action of medical treatment and thermal treatment, so that the treatment effect is greatly accelerated, the plaster is mainly used for treating hyperosteogeny, sciatica, arthralgia and myalgia and the like, has good curative effect and is not easy to relapse.
In order to achieve the purpose, the invention adopts the following technical scheme:
in a first aspect, the invention provides a plaster for treating hyperosteogeny, which is prepared from the following raw medicinal materials in parts by weight: 15-30 parts of parasitic loranthus, 15-30 parts of kadsura pepper stem, 15-30 parts of clematis root, 15-30 parts of earthworm, 15-30 parts of pubescent angelica root, 15-30 parts of cortex acanthopanacis, 15-30 parts of codonopsis pilosula, 15-30 parts of myrrh, 15-30 parts of frankincense, 15-30 parts of tsutsugami, 15-30 parts of tiger palm, 40-60 parts of sargentgloryvine stem, 30-60 parts of Chinese wolfberry, 15-25 parts of angelica, 10-25 parts of ligusticum wallichii, 15-25 parts of dried rehmannia root, 15-25 parts of astragalus root, 15-25 parts of angelica dahurica, 15-25 parts of eucommia bark, 15-25 parts of philippine flemingia root, 15-25 parts of teasel root, 15-25 parts of rhizoma cyperi, 15-25 parts of tortoise plastron, 5-10 parts of liquorice, 10-20 parts of kusnezoff monkshood and 6-9 parts of syngnathus obtaining a; the weight ratio of the natural resin to the bulk drugs is 2-4: 1; the weight ratio of the far infrared ceramic powder to the raw material medicine is 1: 3-5; the addition amount of the penetrating agent is 0.5-1% of the total weight of the raw material medicine and the natural resin.
As a specific technical scheme, the plaster for treating hyperosteogeny is prepared from the following raw medicinal materials in parts by weight: 15 parts of parasitic loranthus, 15 parts of kadsura pepper stem, 15 parts of clematis root, 15 parts of earthworm, 15 parts of pubescent angelica root, 15 parts of slenderstyle acanthopanax bark, 15 parts of pilose asiabell root, 15 parts of myrrh, 15 parts of frankincense, 15 parts of tsutsutsugami, 15 parts of tiger palm, 50 parts of sargentgloryvine stem, 30 parts of medlar, 20 parts of angelica, 10 parts of szechuan lovage rhizome, 20 parts of dried rehmannia root, 20 parts of astragalus root, 20 parts of angelica dahurica, 20 parts of eucommia bark, 20 parts of philippine flemingia root, 20 parts of himalayan teasel root, 15 parts of nutgrass galingale rhizome, 15 parts of tortoise plastron, 5 parts of liquorice, 10 parts of kusnezoff monkshood and 6 parts of sea dragon; the weight ratio of the natural resin to the bulk drugs is 2.5: 1; the weight ratio of the far infrared ceramic powder to the raw material medicine is 1: 4; the addition amount of the penetrating agent is 0.75 percent of the total weight of the raw material medicines and the natural resin.
As a specific technical scheme, the plaster for treating hyperosteogeny is prepared from the following raw medicinal materials in parts by weight: 25 parts of parasitic loranthus, 25 parts of kadsura pepper stem, 25 parts of clematis root, 25 parts of earthworm, 25 parts of pubescent angelica root, 25 parts of slenderstyle acanthopanax bark, 25 parts of pilose asiabell root, 25 parts of myrrh, 25 parts of frankincense, 25 parts of tsutsutsugami, 25 parts of tiger palm, 58 parts of sargentgloryvine stem, 60 parts of medlar, 25 parts of Chinese angelica, 25 parts of szechuan lovage rhizome, 25 parts of dried rehmannia root, 25 parts of astragalus root, 25 parts of dahurian angelica root, 25 parts of eucommia bark, 25 parts of philippine flemingia root, 25 parts of himalayan teasel root, 25 parts of nutgrass galingale rhizome, 25 parts of tortoise plastron, 10 parts of liquorice, 20 parts of kusnezoff monkshood and 9 parts of sea dragon; the weight ratio of the natural resin to the bulk drugs is 2.5: 1; the weight ratio of the far infrared ceramic powder to the raw material medicine is 1: 4; the addition amount of the penetrating agent is 0.75 percent of the total weight of the raw material medicines and the natural resin.
As a specific technical scheme, the plaster for treating hyperosteogeny is prepared from the following raw medicinal materials in parts by weight: 20 parts of parasitic loranthus, 20 parts of kadsura pepper stem, 20 parts of clematis root, 20 parts of earthworm, 20 parts of pubescent angelica root, 20 parts of slenderstyle acanthopanax bark, 30 parts of pilose asiabell root, 30 parts of myrrh, 30 parts of frankincense, 30 parts of tsutsutsugami, 30 parts of tiger palm, 50 parts of sargentgloryvine stem, 50 parts of medlar, 20 parts of Chinese angelica, 20 parts of szechuan lovage rhizome, 20 parts of dried rehmannia root, 20 parts of astragalus root, 20 parts of dahurian angelica root, 20 parts of eucommia bark, 20 parts of philippine flemingia root, 20 parts of himalayan teasel root, 20 parts of nutgrass galingale rhizome, 20 parts of tortoise plastron, 8 parts of liquorice, 15 parts of kusnezoff monkshood and 7 parts of sea dragon; the weight ratio of the natural resin to the bulk drugs is 3: 1; the weight ratio of the far infrared ceramic powder to the raw material medicine is 1: 5; the addition amount of the penetrating agent is 0.5 percent of the total weight of the raw material medicines and the natural resin.
As a specific technical scheme, the plaster for treating hyperosteogeny is prepared from the following raw medicinal materials in parts by weight: 30 parts of parasitic loranthus, 30 parts of kadsura pepper stem, 30 parts of clematis root, 30 parts of earthworm, 30 parts of pubescent angelica root, 30 parts of slenderstyle acanthopanax bark, 28 parts of pilose asiabell root, 28 parts of myrrh, 28 parts of frankincense, 28 parts of tsutsugami, 28 parts of tiger palm, 55 parts of sargentgloryvine stem, 55 parts of medlar, 20 parts of Chinese angelica, 20 parts of szechuan lovage rhizome, 20 parts of dried rehmannia root, 20 parts of astragalus root, 20 parts of dahurian angelica root, 20 parts of eucommia bark, 20 parts of philippine flemingia root, 20 parts of himalayan teasel root, 20 parts of nutgrass galingale rhizome, 20 parts of tortoise plastron, 6 parts of liquorice, 10 parts of kusnezoff monkshood and 6 parts of sea dragon; the weight ratio of the natural resin to the bulk drugs is 2.5: 1; the weight ratio of the far infrared ceramic powder to the raw material medicine is 1: 3; the addition amount of the penetrating agent is 1 percent of the total weight of the raw material medicines and the natural resin.
As a preferred technical scheme, the natural resin is rosin or shellac.
As a preferred technical scheme, the far infrared ceramic powder is sieved, and the particle size is 3500 meshes.
As a preferred technical scheme, the penetrant is azone.
In a second aspect, the present invention provides a preparation method of the plaster for treating hyperosteogeny, including the following steps:
(1) respectively weighing natural resin, far infrared ceramic powder, penetrant and various medicinal materials according to a formula;
(2) pulverizing the medicinal materials into medicinal powder by a low-temperature ultramicro traditional Chinese medicine pulverizer for later use;
(3) putting natural resin into a stainless steel pot, heating to 100 ℃, directly adding the medicinal powder obtained in the step (2) after the natural resin is boiled, adding the far infrared ceramic powder, and continuously stirring for 60-120 min until the mixture is uniform;
(4) adding the penetrating agent and then continuously stirring for 30-60 min;
(5) spreading the paste for forming after completely and uniformly stirring, cooling, bagging and sealing for three days to obtain the plaster for treating the hyperosteogeny.
Preferably, in the step (2), the crushing working temperature is less than 10 ℃.
Preferably, in the step (2), the particle size of the medicinal powder is 1000-5000 meshes.
Preferably, in the step (2), the pulverized medicinal powder can be further extracted by a conventional Chinese herbal medicine extraction and separation method to obtain effective components, and the effective components are processed into medicinal powder with high content of the effective components and the granularity of 1000-5000 meshes. The Chinese herbal medicine extracting and separating method may be supercritical fluid extraction, pressurized countercurrent extraction, molecular distillation, reflux extraction, etc.
Compared with the prior art, the invention provides a plaster for treating hyperosteogeny and a preparation method thereof, and the plaster has the following beneficial effects:
the prescription of the invention is proved by years of practice, improvement, perfection and clinic by the inventor, is used for treating affected parts such as lumbar vertebra hyperosteogeny, cervical vertebra hyperosteogeny and the like by external application, enables the efficacy of the medicine to directly reach the affected parts, and has the characteristics of good curative effect, high cure rate, difficult relapse and the like. In addition, as the far infrared ceramic powder is added into the plaster, the far infrared ray can be emitted, the temperature of subcutaneous deep skin is raised by utilizing the far infrared reaction, the menstrual gas can be stimulated, the immunity is adjusted, the yin and yang are balanced, and the treatment effect is greatly accelerated through the combined action of the medical treatment and the thermal treatment. In addition, the raw materials of the medicinal materials used in the invention have low price and wide sources; the medicine is not decocted at high temperature, so that a large amount of effective components are prevented from being damaged at high temperature, the preparation method is simple, and the production cost is low; the added natural resin has no stimulation to skin, does not generate allergy, has stable matrix and lasting viscosity, does not deform at normal temperature, does not pollute clothes, has better affinity and moisture retention, can be repeatedly torn off and pasted, is convenient to use, and is suitable for the requirements of modern people.
Detailed Description
The technical solutions of the present invention will be described clearly and completely below, and it should be understood that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The invention provides a plaster for treating hyperosteogeny, which is prepared from the following raw medicinal materials in parts by weight: 15-30 parts of parasitic loranthus, 15-30 parts of kadsura pepper stem, 15-30 parts of clematis root, 15-30 parts of earthworm, 15-30 parts of pubescent angelica root, 15-30 parts of cortex acanthopanacis, 15-30 parts of codonopsis pilosula, 15-30 parts of myrrh, 15-30 parts of frankincense, 15-30 parts of tsutsugami, 15-30 parts of tiger palm, 40-60 parts of sargentgloryvine stem, 30-60 parts of Chinese wolfberry, 15-25 parts of angelica, 15-25 parts of ligusticum wallichii, 15-25 parts of dried rehmannia root, 15-25 parts of astragalus root, 15-25 parts of angelica dahurica, 15-25 parts of eucommia bark, 15-25 parts of philippine flemingia root, 15-25 parts of teasel root, 15-25 parts of rhizoma cyperi, 15-25 parts of tortoise plastron, 5-10 parts of liquorice, 10-20 parts of kusnezoff monkshood and 6-9 parts of syngnathus obtaining a; the weight ratio of the natural resin to the bulk drugs is 2-4: 1; the weight ratio of the far infrared ceramic powder to the raw material medicine is 1: 3-5; the addition amount of the penetrating agent is 0.5-1% of the total weight of the raw material medicine and the natural resin.
Wherein the natural resin can be selected from rosin or shellac. The natural resin has no stimulation to skin, does not generate allergy, has stable matrix and lasting viscosity, does not deform at normal temperature, does not pollute clothes, has better affinity and moisture retention, can be repeatedly torn off and pasted, and is convenient to use.
The far infrared ceramic powder is sieved and has particle size of 3500 meshes. The far infrared ceramic powder can emit far infrared rays with the wavelength of 4-14 microns, is easy to absorb by people, utilizes the far infrared reaction to raise the temperature of subcutaneous deep skin, can excite menstrual qi, regulate immunity, balance yin and yang, and greatly accelerates the treatment effect through the combined action of medical treatment and thermal treatment.
The penetrant can be azone, and can promote the effective components of the medicine to enter affected parts.
The medicinal materials have the following properties, flavors, meridians and efficacies:
sang Ji Sheng is bitter and sweet in flavor and neutral in nature. Has effects in strengthening muscle and bone, eliminating rheumatism, dredging channels and collaterals, nourishing blood, and treating soreness of waist and knees, and atrophy and weakness of tendons and bones (compendium of materia Medica).
Kadsura pepper stem, pungent and bitter in flavor, slightly warm in nature. It is combined with Qiang Huo, Du Huo and Dang Gui, etc. to treat arthralgia due to wind-cold-dampness, pain in limbs and joints, spasm of tendons and vessels, and difficulty in flexion and extension (Renzhen of materia Medica).
Clematis chinensis, pungent and salty in flavor, warm in nature and slight in toxicity (originally sutural origin). Can be used for treating rheumatalgia, numbness of limbs, spasm of tendons and vessels, and difficulty in flexion and extension.
Lumbricus, Lumbricus is salty in taste and cold in nature, and has effects of clearing heat, arresting convulsion, dredging collaterals, relieving asthma, and promoting urination. Earthworm is good at passing through meridians and collaterals, and is used for the syndrome of obstruction of meridians and collaterals, unsmooth blood vessels and adverse limb joints caused by various reasons.
Du Huo is bitter in taste, pungent in flavor and slightly warm in nature. Has the functions of expelling wind and dampness, dispelling cold and relieving pain. Can be used for treating arthralgia due to wind-cold-dampness, lumbago, gonalgia, headache due to wind-cold evil, and toothache. It can be used for treating arthralgia due to wind-cold-dampness, and pain of muscle, waist, back, and hand and foot. It is usually combined with sang Ji Sheng and Du Zhong to treat chronic deficiency of healthy qi, soreness and weakness of waist and knees and difficulty in flexion and extension of joints (Ben Cao Zheng).
Wu Jia Pi, pungent and bitter in flavor and warm in nature. Has the functions of dispelling wind-damp, tonifying liver and kidney, strengthening tendons and bones, inducing diuresis and reducing edema (compendium of materia Medica).
Codonopsis pilosula is sweet and mild in taste and is nontoxic. Has the effects of strengthening the body resistance, consolidating the constitution, protecting the vitality and assisting the principal drugs to achieve the effects of tonifying middle-jiao and Qi, quenching thirst, strengthening the spleen and tonifying the lung, nourishing the blood and promoting the production of body fluid. The book of materia Medica: dangshen is much less distant from ginseng in its potency, because it can tonify spleen and stomach, moisten lung and promote fluid production, and tendon can transport qi of middle energizer.
Mo Yao, pungent and bitter in flavor and neutral in nature. It has the effects of removing blood stasis, relieving pain, eliminating swelling, and promoting granulation (recorded in the West records of the science and the Zhong Can).
Ru Xiang is bitter, pungent and warm in flavor. The book Ben Cao Hui Yan (treatise on materia Medica): olibanum, a Chinese medicine for promoting blood circulation, dispelling wind, relaxing muscles and tendons and alleviating pain. … … it is also indicated for traumatic injuries, fractures bones and muscles, and postpartum qi and blood attacking thorns and pain in heart and abdomen, and it is specially indicated for salty taste, pungent flavor, blood-dispersing and pus-expelling, and qi-flowing and stagnation-resolving. "
It is pungent, pungent and bitter with warm property. It can be used for treating arthralgia due to wind-cold-dampness, neck stiffness, spasm of muscles, soreness and pain of bone joints, edema due to wind-damp evil, superficial infection, and skin ulcer.
Tiger paw, bitter and pungent in flavor, warm in nature and with little toxicity. Dispel wind and stop spasm, dissipate nodulation and resolve swelling. Can be used for treating hemiplegia, epilepsy, infantile convulsion, and tetanus; it is used externally to treat carbuncle and swelling. The book Jing: "Xintong, cold and heat accumulating in qi, accumulation of bent girder, injury of tendon, atrophy, spasm and diuresis". It should be used with cautions for pregnant women, and should be taken orally.
Sargentodoxa cuneata, bitter in taste and neutral in nature. Clearing away heat and toxic material, promoting blood circulation, dispelling pathogenic wind and relieving pain. Can be used for treating abdominal pain due to intestinal abscess, pyocutaneous disease due to heat toxin, amenorrhea, dysmenorrhea, traumatic injury, swelling and pain, and rheumatalgia. Treating traumatic injury: appropriate amount of caulis Sargentodoxae and rhizoma Drynariae. Pounded and applied to the affected area. (Manual of Chinese herbal medicine in rural areas in Hunan), pregnant women should take with caution.
Medlar, sweet in flavor and mild in taste. Dietary therapy Ben Cao: strengthen tendons and resist aging, dispel wind, tonify tendons and bones, benefit people and relieve consumptive disease.
Dang Gui is sweet and pungent in flavor and warm in nature. Tonify blood, activate blood, moisten intestines to relieve constipation. Can be used for treating blood deficiency, sallow complexion, asthenia cold abdominal pain, rheumatalgia, traumatic injury, superficial infection, pyocutaneous disease, intestinal dryness and constipation. The wine angelica sinensis can activate blood and promote menstruation. Can be used for treating rheumatalgia and traumatic injury.
Chuan Xiong is pungent, slightly bitter and warm in flavor. Has effects in promoting qi circulation, dispersing depressed vital energy, expelling pathogenic wind, removing dampness, promoting blood circulation, and relieving pain.
Sheng Di Huang is sweet, bitter and cold in nature. Has effects in nourishing yin, invigorating kidney, nourishing blood, tonifying blood, and cooling blood.
Huang Qi is sweet in flavor and slightly warm in nature. Has effects of invigorating qi, consolidating superficial resistance, arresting sweating, promoting granulation, inducing diuresis, and relieving swelling. In the book of jin Kui Yao L ü e, Huang Qi is used for tonifying qi and promoting the circulation of qi and blood, and is used for qi deficiency and blood stagnation, numbness of skin, pain of limbs, or hemiplegia.
Bai Zhi is pungent in flavor and warm in nature. Has the effects of relieving exterior syndrome, dispelling cold, dispelling pathogenic wind, relieving pain, dredging nasal orifice, eliminating dampness, relieving leukorrhagia, relieving swelling, expelling pus, dispelling pathogenic wind, and relieving itching.
Du Zhong is sweet and slightly pungent in flavor and warm in nature. Has the effects of nourishing liver and kidney, strengthening tendons and bones, treating soreness and pain of waist and back, flaccidity of feet and knees and the like.
Qianjin, mild in nature, sweet and slightly astringent in taste. Dispelling pathogenic wind and removing dampness, strengthening tendons and bones, promoting blood circulation and removing toxic substances, and dispelling pathogenic wind and removing dampness. For arthralgia of hands and feet, pain of waist due to wind-damp, traumatic injuries, etc., it can relax tendons and activate collaterals in Ling nan Bing Yao Lu.
Xu Duan is slightly warm in nature and bitter and pungent in flavor. It has effects in strengthening tendons and bones, treating fracture, and preventing metrorrhagia and metrostaxis (entry in the book of Olympic treatises).
Cyperus rotundus, pungent, slightly bitter, slightly sweet in flavor, neutral in nature. Has the functions of promoting the circulation of qi, resolving stagnation, regulating menstruation, relieving pain and the like, and belongs to qi-regulating medicines.
Gui ban is salty and sweet in flavor and slightly cold in nature. Has the functions of nourishing yin, suppressing yang, tonifying kidney, strengthening bone, nourishing blood, tonifying heart, strengthening channel, stopping metrorrhagia, etc.
Licorice root, radix Glycyrrhizae is sweet in flavor and neutral in nature. Has the effects of invigorating spleen and replenishing qi, clearing away heat and toxic materials, eliminating phlegm and relieving cough, relieving spasm and pain, and harmonizing the medicines. In the recipe, it is mainly indicated for relieving toxicity and toxicity of herbs.
Kusnezoff monkshood root, pungent and bitter in flavor and warm in nature. Has the effects of dispelling pathogenic wind, removing dampness, warming channels and relieving pain. Is used for treating cold-dampness and blood stasis in channels and collaterals, limb sinew and vessel contracture pain, and joint flexion and extension difficulty: it is combined with Chuan Wu, Di Long and Ru Xiang (He Ji Ju Fang).
Hailong, salty and sweet in taste, warm in nature. Modern practical traditional Chinese medicine: it is used as tonic and has exciting effect, and can be used for treating mental exhaustion of the elderly and the weak, and treating blood and qi pain.
The invention takes the loranthus parasiticus, the futokadsura stem, the clematis root, the earthworm, the radix angelicae pubescentis and the cortex acanthopanacis as main medicines, and the six medicines are compatible, have the efficacies of dispelling wind and removing dampness, dispelling cold and relieving pain, tonifying liver and kidney, strengthening tendons and bones, removing spasm of muscles and tendons, benefiting blood and dredging collaterals, and promoting blood circulation and relieving pain, and are monarch medicines of the formula; the seven medicines are compatible and have the efficacies of strengthening the middle-jiao and replenishing qi, nourishing blood and promoting the production of body fluid, strengthening the body resistance and strengthening the primordial qi, tonifying muscles and bones, promoting blood circulation and dispelling wind, dispelling wind and relieving spasm, relaxing muscles and tendons and relieving pain, and eliminating stagnation and reducing swelling, and are ministerial medicines of the prescription; chinese angelica, szechuan lovage rhizome, dried rehmannia root, membranous milkvetch root, dahurian angelica root, eucommia bark, philippine flemingia root, himalayan teasel root, nutgrass galingale rhizome and tortoise plastron are taken as assistant drugs, and the assistant drugs have the efficacies of nourishing blood and enriching blood, promoting blood circulation and removing toxin, tonifying qi and consolidating exterior, promoting qi circulation and removing obstruction in the channels, dispelling wind and removing dampness, strengthening tendons and bones, relaxing tendons and activating collaterals and relieving pain, and are adjuvant drugs of the prescription; the liquorice, the kusnezoff monkshood root and the sea dragon are used as guiding medicaments, and the three are compatible, so that the traditional Chinese medicine composition has the effects of harmonizing the medicaments, warming channels, relieving pain, strengthening physique and guiding the medicaments to win the medicinal herbs, and is a guiding medicament of the formula. The prescription of the invention is prepared from twenty-six medicinal materials which are compatible with each other, and the plaster for external application is prepared by natural resin, far infrared ceramic powder and penetrant, and has the overall efficacies of dispelling wind and eliminating dampness, promoting blood circulation and removing blood stasis, dredging collaterals and relieving pain, strengthening tendons and bones and the like. Meanwhile, as the far infrared ceramic powder is added into the plaster, far infrared heat energy can be emitted, meridian qi can be stimulated, immunity can be adjusted, yin and yang can be balanced, and the treatment effect can be greatly accelerated through the combined action of medical treatment and thermal treatment; the added natural resin has no stimulation to skin, does not generate allergy, has stable matrix and lasting viscosity, and the plaster can not deform at normal temperature and can not pollute clothes.
The present invention is described in further detail below by means of detailed examples.
Example 1
The embodiment provides a plaster for treating hyperosteogeny, which is prepared from raw material medicines, natural resin, far infrared ceramic powder and a penetrating agent. The raw material medicaments comprise the following medicinal materials in parts by weight: 15 parts of parasitic loranthus, 15 parts of kadsura pepper stem, 15 parts of clematis root, 15 parts of earthworm, 15 parts of pubescent angelica root, 15 parts of slenderstyle acanthopanax bark, 15 parts of pilose asiabell root, 15 parts of myrrh, 15 parts of frankincense, 15 parts of tsutsutsugami, 15 parts of tiger palm, 50 parts of sargentgloryvine stem, 30 parts of medlar, 20 parts of Chinese angelica, 10 parts of szechuan lovage rhizome, 20 parts of dried rehmannia root, 20 parts of astragalus root, 20 parts of dahurian angelica root, 20 parts of eucommia bark, 20 parts of philippine flemingia root, 20 parts of himalayan teasel root, 15 parts of nutgrass galingale rhizome, 15 parts of tortoise plastron, 5 parts of liquorice, 10 parts of kusnezoff monkshood and 6 parts of sea dragon. The weight ratio of the natural resin to the bulk drugs is 2.5: 1; the natural resin is rosin. The weight ratio of the far infrared ceramic powder to the raw material medicine is 1: 4; the far infrared ceramic powder is sieved and has particle size of 3500 meshes. The penetrant is azone, and the addition amount of the penetrant is 0.75% of the total weight of the raw material medicines and the natural resin.
The preparation method of the plaster for treating hyperosteogeny comprises the following steps:
(1) weighing the medicinal materials according to a formula, which specifically comprises the following steps: 30g of parasitic loranthus, 30g of kadsura pepper stem, 30g of clematis root, 30g of earthworm, 30g of pubescent angelica root, 30g of slenderstyle acanthopanax bark, 30g of codonopsis pilosula, 30g of myrrh, 30g of frankincense, 30g of tsutsutsugami, 30g of tiger palm, 100g of sargentgloryvine stem, 60g of medlar, 40g of angelica, 20g of ligusticum wallichii, 40g of radix rehmanniae, 40g of astragalus, 40g of angelica dahurica, 40g of eucommia bark, 40g of philippine flemingia root, 40g of teasel root, 40g of nutgrass galingale rhizome, 30g of tortoise plastron, 10g of liquorice, 20g of kusnezoff monkshood and 12g of syngnathus totaling 902 g; weighing 2255g of natural resin, 225.6g of far infrared ceramic powder and 23.6g of penetrating agent according to the formula.
(2) Pulverizing the medicinal materials into medicinal powder with a particle size of 5000 meshes by using a low-temperature ultramicro traditional Chinese medicine pulverizer, wherein the pulverizing temperature is less than 10 ℃ for later use;
(3) putting natural resin into a stainless steel pot, heating to 100 ℃, directly adding the medicinal powder in the step (2) after the natural resin is boiled, adding the far infrared ceramic powder, and continuously stirring for 90min to be uniform;
(4) adding penetrant, and stirring for 50 min;
(5) spreading the paste for forming after completely and uniformly stirring, processing into 5g of paste per patch, cooling, bagging and sealing for three days to obtain the plaster for treating the hyperosteogeny.
Example 2
The embodiment provides a plaster for treating hyperosteogeny, which is prepared from raw material medicines, natural resin, far infrared ceramic powder and a penetrating agent. The raw material medicaments comprise the following medicinal materials in parts by weight: 25 parts of parasitic loranthus, 25 parts of kadsura pepper stem, 25 parts of clematis root, 25 parts of earthworm, 25 parts of pubescent angelica root, 25 parts of slenderstyle acanthopanax bark, 25 parts of pilose asiabell root, 25 parts of myrrh, 25 parts of frankincense, 25 parts of tsutsutsugami, 25 parts of tiger palm, 58 parts of sargentgloryvine stem, 60 parts of medlar, 25 parts of Chinese angelica, 25 parts of szechuan lovage rhizome, 25 parts of dried rehmannia root, 25 parts of astragalus root, 25 parts of dahurian angelica root, 25 parts of eucommia bark, 25 parts of philippine flemingia root, 25 parts of himalayan teasel root, 25 parts of nutgrass galingale rhizome, 25 parts of tortoise plastron, 10 parts of liquorice, 20 parts of kusnezoff monkshood and 9 parts of sea dragon. The weight ratio of the natural resin to the bulk drugs is 2.5: 1; the natural resin is rosin. The weight ratio of the far infrared ceramic powder to the raw material medicine is 1: 4; the far infrared ceramic powder is sieved and has particle size of 3500 meshes. The penetrant is azone, and the addition amount of the penetrant is 0.75% of the total weight of the raw material medicines and the natural resin.
The preparation method of the plaster for treating hyperosteogeny comprises the following steps:
(1) weighing the medicinal materials according to a formula, which specifically comprises the following steps: 50g of parasitic loranthus, 50g of kadsura pepper stem, 50g of clematis root, 50g of earthworm, 50g of pubescent angelica root, 50g of slenderstyle acanthopanax bark, 50g of codonopsis pilosula, 50g of myrrh, 50g of frankincense, 50g of tsutsutsugami, 50g of tiger palm, 116g of sargentgloryvine stem, 120g of medlar, 50g of angelica, 50g of ligusticum wallichii, 50g of radix rehmanniae, 50g of astragalus mongholicus, 50g of angelica dahurica, 50g of eucommia bark, 50g of philippine flemingia root, 50g of teasel root, 50g of rhizoma cyperi, 50g of tortoise plastron, 20g of liquorice, 40g of kusnezoff monkshood and 18g of syngnathus totaling 1364 g; according to the formula, 3410g of natural resin, 341g of far infrared ceramic powder and 35.8g of penetrating agent are respectively weighed.
(2) Pulverizing the medicinal materials into medicinal powder with a particle size of 5000 meshes by using a low-temperature ultramicro traditional Chinese medicine pulverizer, wherein the pulverizing temperature is less than 10 ℃ for later use;
(3) putting natural resin into a stainless steel pot, heating to 100 ℃, directly adding the medicinal powder in the step (2) after the natural resin is boiled, adding the far infrared ceramic powder, and continuously stirring for 90min to be uniform;
(4) adding penetrant, and stirring for 50 min;
(5) spreading the paste for forming after completely and uniformly stirring, processing into 5g of paste per patch, cooling, bagging and sealing for three days to obtain the plaster for treating the hyperosteogeny.
Example 3
The embodiment provides a plaster for treating hyperosteogeny, which is prepared from raw material medicines, natural resin, far infrared ceramic powder and a penetrating agent. The raw material medicaments comprise the following medicinal materials in parts by weight: 20 parts of parasitic loranthus, 20 parts of kadsura pepper stem, 20 parts of clematis root, 20 parts of earthworm, 20 parts of pubescent angelica root, 20 parts of slenderstyle acanthopanax bark, 30 parts of pilose asiabell root, 30 parts of myrrh, 30 parts of frankincense, 30 parts of tsutsutsugami, 30 parts of tiger palm, 50 parts of sargentgloryvine stem, 50 parts of medlar, 20 parts of Chinese angelica, 20 parts of szechuan lovage rhizome, 20 parts of dried rehmannia root, 20 parts of astragalus root, 20 parts of dahurian angelica root, 20 parts of eucommia bark, 20 parts of philippine flemingia root, 20 parts of himalayan teasel root, 20 parts of nutgrass galingale rhizome, 20 parts of tortoise plastron, 8 parts of liquorice, 15 parts of kusnezoff monkshood and 7 parts of sea dragon. The weight ratio of the natural resin to the bulk drugs is 3: 1; the natural resin is shellac. The weight ratio of the far infrared ceramic powder to the raw material medicine is 1: 5; the far infrared ceramic powder is sieved and has particle size of 3500 meshes. The penetrant is azone, and the addition amount of the penetrant is 0.5% of the total weight of the raw material medicines and the natural resin.
The preparation method of the plaster for treating hyperosteogeny comprises the following steps:
(1) weighing the medicinal materials according to a formula, which specifically comprises the following steps: 40g of parasitic loranthus, 40g of kadsura pepper stem, 40g of clematis root, 40g of earthworm, 40g of pubescent angelica root, 40g of slenderstyle acanthopanax bark, 60g of codonopsis pilosula, 60g of myrrh, 60g of frankincense, 60g of tsutsutsugami, 60g of tiger palm, 100g of sargentgloryvine stem, 100g of medlar, 40g of angelica, 40g of ligusticum wallichii, 40g of radix rehmanniae, 40g of astragalus mongholicus, 40g of angelica dahurica, 40g of eucommia bark, 40g of philippine flemingia root, 40g of teasel root, 40g of rhizoma cyperi, 40g of tortoise plastron, 16g of liquorice, 30g of kusnezoff monkshood and 14g of syngnathus totaling 1200 g; 3600g of natural resin, 240g of far infrared ceramic powder and 24g of penetrating agent are respectively weighed according to the formula.
(2) Pulverizing the medicinal materials into 2000-mesh powder with a low-temperature ultramicro Chinese medicinal pulverizer at a temperature of less than 10 deg.C;
(3) putting natural resin into a stainless steel pot, heating to 100 ℃, directly adding the medicinal powder in the step (2) after the natural resin is boiled, adding the far infrared ceramic powder, and continuously stirring for 60min until the mixture is uniform;
(4) adding penetrant, and stirring for 60 min;
(5) spreading the paste for forming after completely and uniformly stirring, processing into 5g of paste per patch, cooling, bagging and sealing for three days to obtain the plaster for treating the hyperosteogeny.
Example 4
The embodiment provides a plaster for treating hyperosteogeny, which is prepared from raw material medicines, natural resin, far infrared ceramic powder and a penetrating agent. The raw material medicaments comprise the following medicinal materials in parts by weight: 30 parts of parasitic loranthus, 30 parts of kadsura pepper stem, 30 parts of clematis root, 30 parts of earthworm, 30 parts of pubescent angelica root, 30 parts of slenderstyle acanthopanax bark, 28 parts of pilose asiabell root, 28 parts of myrrh, 28 parts of frankincense, 28 parts of tsutsugami, 28 parts of tiger palm, 55 parts of sargentgloryvine stem, 55 parts of medlar, 20 parts of Chinese angelica, 20 parts of szechuan lovage rhizome, 20 parts of dried rehmannia root, 20 parts of astragalus root, 20 parts of dahurian angelica root, 20 parts of eucommia bark, 20 parts of philippine flemingia root, 20 parts of himalayan teasel root, 20 parts of nutgrass galingale rhizome, 20 parts of tortoise plastron, 6 parts of liquorice, 10 parts of kusnezoff monkshood and 6 parts of sea dragon. The weight ratio of the natural resin to the bulk drugs is 2.5: 1; the natural resin is rosin. The weight ratio of the far infrared ceramic powder to the raw material medicine is 1: 3; the far infrared ceramic powder is sieved and has particle size of 3500 meshes. The penetrant is azone, and the addition amount of the penetrant is 1% of the total weight of the raw material medicines and the natural resin.
The preparation method of the plaster for treating hyperosteogeny comprises the following steps:
(1) weighing the medicinal materials according to a formula, which specifically comprises the following steps: 60g of parasitic loranthus, 60g of kadsura pepper stem, 60g of clematis root, 60g of earthworm, 60g of pubescent angelica root, 60g of slenderstyle acanthopanax bark, 56g of codonopsis pilosula, 56g of myrrh, 56g of frankincense, 56g of tsutsutsugami, 56g of tiger palm, 110g of sargentgloryvine stem, 110g of medlar, 40g of angelica, 40g of ligusticum wallichii, 40g of radix rehmanniae, 40g of astragalus mongholicus, 40g of angelica dahurica, 40g of eucommia bark, 40g of philippine flemingia root, 40g of teasel root, 40g of rhizoma cyperi, 40g of tortoise plastron, 12g of liquorice, 20g of kusnezoff monkshood and 12g of syngnathus calculated by 1304 g; 3260g of natural resin, 434.6g of far infrared ceramic powder and 45.6g of penetrating agent are respectively weighed according to the formula.
(2) Pulverizing the medicinal materials into 3000 mesh powder with a low-temperature ultramicro Chinese medicinal pulverizer at a temperature of less than 10 deg.C;
(3) putting natural resin into a stainless steel pot, heating to 100 ℃, directly adding the medicinal powder in the step (2) after the natural resin is boiled, adding the far infrared ceramic powder, and continuously stirring for 120min to be uniform;
(4) adding penetrant, and stirring for 30 min;
(5) spreading the paste for forming after completely and uniformly stirring, processing into 5g of paste per patch, cooling, bagging and sealing for three days to obtain the plaster for treating the hyperosteogeny.
Example 1 is the preferred embodiment.
In order to verify the curative effect of the invention, clinical observation is carried out on the treatment conditions of 150 patients with cervical vertebra hyperosteogeny and lumbar vertebra hyperosteogeny, and the specific analysis is as follows:
(one) case selection
(1) Sex: 83 men and 67 women, the ratio of men to women is 1.24: 1, and the prevalence rate of men is slightly higher than that of women. 92 cases of lumbar vertebra hyperosteogeny and 58 cases of cervical vertebra hyperosteogeny.
(2) Age: see Table 1
TABLE 1
| Age (age) | Less than 20 | 21～30 | 31～40 | 41～50 | 51～60 | 61～70 | 71 or more |
| Number of examples | 0 | 2 | 14 | 28 | 63 | 36 | 7 |
(3) The course of the disease is as follows: see Table 2
TABLE 2
(II) diagnostic criteria
1. Hyperosteogeny of cervical vertebra: local pain of cervical vertebrae, stiffness of neck, limitation of movement and pain of head and shoulder. Some symptoms are also accompanied by symptoms of heaviness, numbness, weakness, heavy head, dizziness, blurred vision, insomnia, amnesia, chest distress, dysphoria, etc. of the upper limbs. X-ray shows hyperosteogeny in cervical vertebra.
2. Lumbar vertebrae hyperosteogeny: soreness, distending pain, stiffness and fatigue of lumbar and lumbar soft tissues, and even limited stooping. The X-ray film shows osteophyte hyperplasia of the vertebral body and narrow intervertebral space.
(III) methods of treatment
The plaster for treating hyperosteogeny in the embodiment 1 is externally applied to the affected part, and is applied twice a day, once in the morning and at night, 1 plaster each time, and 10-12 hours each time; generally, the treatment lasts for 1-3 months, and the time depends on the severity of the disease. It is forbidden for women in menstrual period, pregnant woman and lactation period. During the administration period, heavy physical labor is prohibited, and sour and spicy food is prohibited.
(IV) therapeutic Effect analysis
(1) Standard of therapeutic effect
And (3) curing: the symptoms disappeared and the labor recovered. Improvement: the symptoms essentially disappear, and are painful only during labor. And (4) invalidation: the symptoms and signs are unchanged.
(2) And (4) analyzing results: see Table 3
TABLE 3
| Bony spur sites | Number of examples | Cure of disease | Improvement of life | Invalidation | Recurrence of disease |
| Cervical vertebrae | 58 | 48 | 8 | 1 | 1 |
| Lumbar vertebrae | 92 | 79 | 11 | 1 | 1 |
| Total of | 150 | 127 | 19 | 2 | 2 |
| Percentage (%) | 84.67％ | 12.67％ | 1.33％ | 1.33％ |
The prescription of the invention is prepared from twenty-six medicinal materials which are compatible with each other, and the plaster for external application is prepared by natural resin, far infrared ceramic powder and penetrant, and has the efficacies of dispelling wind and eliminating dampness, promoting blood circulation and removing blood stasis, dredging collaterals and relieving pain, strengthening tendons and bones, and the like. The invention adopts the principles of promoting blood circulation, relieving pain, strengthening muscles and bones, regulating qi, promoting blood circulation and warming and dredging channels and collaterals, contains two factors of eliminating evil and strengthening body resistance, combines the inside and the outside, and has the combined action of medical treatment and thermal treatment, thereby greatly accelerating the treatment effect and having good effect of treating the hyperosteogeny. 150 cases of lumbar vertebra and cervical vertebra hyperosteogeny are treated, the majority of treatment course is 1 month, the minority is 2 months, and the individual treatment course is 3 months, wherein 127 cases are clinically cured, 84.67%, 19 cases are improved, 12.67%, the total effective rate is 97.34%, 2 cases are ineffective, 1.33%, and 2 cases are recurred, and 1.33%. Therefore, the invention has better beneficial effect.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Furthermore, it should be understood that although the present description refers to embodiments, not every embodiment may contain only a single embodiment, and such description is for clarity only, and those skilled in the art should integrate the description, and the embodiments may be combined as appropriate to form other embodiments understood by those skilled in the art.
Claims (10)
1. The plaster for treating hyperosteogeny is characterized by being prepared from the following raw medicinal materials in parts by weight: 15-30 parts of parasitic loranthus, 15-30 parts of kadsura pepper stem, 15-30 parts of clematis root, 15-30 parts of earthworm, 15-30 parts of pubescent angelica root, 15-30 parts of cortex acanthopanacis, 15-30 parts of codonopsis pilosula, 15-30 parts of myrrh, 15-30 parts of frankincense, 15-30 parts of tsutsugami, 15-30 parts of tiger palm, 40-60 parts of sargentgloryvine stem, 30-60 parts of Chinese wolfberry, 15-25 parts of angelica, 10-25 parts of ligusticum wallichii, 15-25 parts of dried rehmannia root, 15-25 parts of astragalus root, 15-25 parts of angelica dahurica, 15-25 parts of eucommia bark, 15-25 parts of philippine flemingia root, 15-25 parts of teasel root, 15-25 parts of rhizoma cyperi, 15-25 parts of tortoise plastron, 5-10 parts of liquorice, 10-20 parts of kusnezoff monkshood and 6-9 parts of syngnathus obtaining a; the weight ratio of the natural resin to the bulk drugs is 2-4: 1; the weight ratio of the far infrared ceramic powder to the raw material medicine is 1: 3-5; the addition amount of the penetrating agent is 0.5-1% of the total weight of the raw material medicine and the natural resin.
2. The plaster for treating hyperosteogeny according to claim 1, which is prepared from the following raw materials in parts by weight: 15 parts of parasitic loranthus, 15 parts of kadsura pepper stem, 15 parts of clematis root, 15 parts of earthworm, 15 parts of pubescent angelica root, 15 parts of slenderstyle acanthopanax bark, 15 parts of pilose asiabell root, 15 parts of myrrh, 15 parts of frankincense, 15 parts of tsutsutsugami, 15 parts of tiger palm, 50 parts of sargentgloryvine stem, 30 parts of medlar, 20 parts of angelica, 10 parts of szechuan lovage rhizome, 20 parts of dried rehmannia root, 20 parts of astragalus root, 20 parts of angelica dahurica, 20 parts of eucommia bark, 20 parts of philippine flemingia root, 20 parts of himalayan teasel root, 15 parts of nutgrass galingale rhizome, 15 parts of tortoise plastron, 5 parts of liquorice, 10 parts of kusnezoff monkshood and 6 parts of sea dragon; the weight ratio of the natural resin to the bulk drugs is 2.5: 1; the weight ratio of the far infrared ceramic powder to the raw material medicine is 1: 4; the addition amount of the penetrating agent is 0.75 percent of the total weight of the raw material medicines and the natural resin.
3. The plaster for treating hyperosteogeny according to claim 1, which is prepared from the following raw materials in parts by weight: 25 parts of parasitic loranthus, 25 parts of kadsura pepper stem, 25 parts of clematis root, 25 parts of earthworm, 25 parts of pubescent angelica root, 25 parts of slenderstyle acanthopanax bark, 25 parts of pilose asiabell root, 25 parts of myrrh, 25 parts of frankincense, 25 parts of tsutsutsugami, 25 parts of tiger palm, 58 parts of sargentgloryvine stem, 60 parts of medlar, 25 parts of Chinese angelica, 25 parts of szechuan lovage rhizome, 25 parts of dried rehmannia root, 25 parts of astragalus root, 25 parts of dahurian angelica root, 25 parts of eucommia bark, 25 parts of philippine flemingia root, 25 parts of himalayan teasel root, 25 parts of nutgrass galingale rhizome, 25 parts of tortoise plastron, 10 parts of liquorice, 20 parts of kusnezoff monkshood and 9 parts of sea dragon; the weight ratio of the natural resin to the bulk drugs is 2.5: 1; the weight ratio of the far infrared ceramic powder to the raw material medicine is 1: 4; the addition amount of the penetrating agent is 0.75 percent of the total weight of the raw material medicines and the natural resin.
4. The plaster for treating hyperosteogeny according to claim 1, which is prepared from the following raw materials in parts by weight: 30 parts of parasitic loranthus, 30 parts of kadsura pepper stem, 30 parts of clematis root, 30 parts of earthworm, 30 parts of pubescent angelica root, 30 parts of slenderstyle acanthopanax bark, 28 parts of pilose asiabell root, 28 parts of myrrh, 28 parts of frankincense, 28 parts of tsutsugami, 28 parts of tiger palm, 55 parts of sargentgloryvine stem, 55 parts of medlar, 20 parts of Chinese angelica, 20 parts of szechuan lovage rhizome, 20 parts of dried rehmannia root, 20 parts of astragalus root, 20 parts of dahurian angelica root, 20 parts of eucommia bark, 20 parts of philippine flemingia root, 20 parts of himalayan teasel root, 20 parts of nutgrass galingale rhizome, 20 parts of tortoise plastron, 6 parts of liquorice, 10 parts of kusnezoff monkshood and 6 parts of sea dragon; the weight ratio of the natural resin to the bulk drugs is 2.5: 1; the weight ratio of the far infrared ceramic powder to the raw material medicine is 1: 3; the addition amount of the penetrating agent is 1 percent of the total weight of the raw material medicines and the natural resin.
5. A plaster for the treatment of hyperosteogeny according to any one of claims 1 to 4, wherein said natural resin is rosin or shellac.
6. The plaster for treating hyperosteogeny according to any one of claims 1 to 4, wherein the far infrared ceramic powder is sieved and has a particle size of 3500 meshes.
7. A plaster for the treatment of hyperosteogeny according to any one of claims 1 to 4, wherein said penetrant is azone.
8. The method for preparing a plaster for treating hyperosteogeny according to any one of claims 1 to 4, comprising the steps of:
(1) respectively weighing natural resin, far infrared ceramic powder, penetrant and various medicinal materials according to a formula;
(2) pulverizing the medicinal materials into medicinal powder by a low-temperature ultramicro traditional Chinese medicine pulverizer for later use;
(3) putting natural resin into a stainless steel pot, heating to 100 ℃, directly adding the medicinal powder obtained in the step (2) after the natural resin is boiled, adding the far infrared ceramic powder, and continuously stirring for 60-120 min until the mixture is uniform;
(4) adding the penetrating agent and then continuously stirring for 30-60 min;
(5) spreading the paste for forming after completely and uniformly stirring, cooling, bagging and sealing for three days to obtain the plaster for treating the hyperosteogeny.
9. The method for preparing a plaster for treating hyperosteogeny according to claim 8, wherein the pulverization operation temperature in step (2) is less than 10 ℃.
10. The method of claim 8, wherein in the step (2), the particle size of the powder is 1000-5000 mesh.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110911510.4A CN113425794A (en) | 2021-08-10 | 2021-08-10 | Plaster for treating hyperosteogeny and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110911510.4A CN113425794A (en) | 2021-08-10 | 2021-08-10 | Plaster for treating hyperosteogeny and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113425794A true CN113425794A (en) | 2021-09-24 |
Family
ID=77763087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110911510.4A Pending CN113425794A (en) | 2021-08-10 | 2021-08-10 | Plaster for treating hyperosteogeny and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113425794A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101569667A (en) * | 2008-04-28 | 2009-11-04 | 唐元成 | Medicament for treating hyperosteogeny and lumbar intervertebral disc protrusion |
| CN103656027A (en) * | 2013-12-19 | 2014-03-26 | 王星月 | External-application plaster for treating hyperosteogeny |
-
2021
- 2021-08-10 CN CN202110911510.4A patent/CN113425794A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101569667A (en) * | 2008-04-28 | 2009-11-04 | 唐元成 | Medicament for treating hyperosteogeny and lumbar intervertebral disc protrusion |
| CN103656027A (en) * | 2013-12-19 | 2014-03-26 | 王星月 | External-application plaster for treating hyperosteogeny |
Non-Patent Citations (1)
| Title |
|---|
| 邓国强: "温阳养血汤治疗骨质增生138例", 《陕西中医》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107007724B (en) | A Chinese medicinal liquid for health protection, and its preparation method | |
| CN102626505A (en) | Massaging paste based on Chinese medicinal herbs and preparation method thereof | |
| CN100493554C (en) | Blood-activating kidney-tonifying pellet | |
| CN104721614A (en) | Traditional Chinese medicine preparation for treating dearticulation and preparation method of traditional Chinese medicine preparation | |
| CN103961513A (en) | Traditional Chinese medicine preparation for fracture nursing and preparation method thereof | |
| CN104623617B (en) | Medicine for treating osteoarticular diseases and preparation method and using method thereof | |
| CN113425794A (en) | Plaster for treating hyperosteogeny and preparation method thereof | |
| CN102836276B (en) | Bone spur softening pill for treating osteoarthritis | |
| CN101168041B (en) | Rheumatism treating medicine | |
| CN105641330A (en) | Traditional Chinese medicine composition for invigorating kidney and strengthening yang | |
| CN103961555A (en) | Traditional Chinese medicine preparation for treating peripheral nerve injury and preparation method thereof | |
| CN104225534A (en) | Ointment for treating waist, shoulder and foot rheumatism and preparation method of ointment | |
| CN113413433A (en) | A Chinese medicinal pill for treating hyperosteogeny, and its preparation method | |
| CN107929696B (en) | External traditional Chinese medicine composition for relieving swelling, relaxing muscles and setting bones as well as preparation method and application thereof | |
| CN115645503B (en) | Medicinal composition and acupoint application paste for treating chronic pain diseases | |
| CN103893348B (en) | A kind of Chinese medicine ointment for the treatment of radioactive skin injury and preparation method | |
| CN103705712B (en) | One treats osteoporotic Chinese medicine preparation and preparation method | |
| CN105796860A (en) | Quick-acting bone setting Yi medicine | |
| CN105902670A (en) | Medicine used for traumatic hairline fracture and preparation method | |
| CN105687511A (en) | Traditional Chinese medicine composition for treating rheumatalgia and hand and foot numbness and preparation method thereof | |
| CN105412484A (en) | Medicine for treating arthralgia, and preparation method thereof | |
| CN114699490A (en) | Traditional Chinese medicine oral preparation for treating cervical spondylosis vertigo | |
| CN113197939A (en) | Traditional Chinese medicine composition for treating rheumatic cold arthralgia | |
| CN115554356A (en) | Traditional Chinese medicine composition, plaster containing traditional Chinese medicine composition and preparation method of plaster | |
| CN112263658A (en) | External medicinal liquor for treating body joint soreness, swelling, numbness and pain and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210924 |
|
| RJ01 | Rejection of invention patent application after publication |